A Phase I Study of Ixabepilone Combined With Dasatinib in Patients With Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 30 May 2012
At a glance
- Drugs Dasatinib; Ixabepilone
- Indications Solid tumours
- Focus Adverse reactions
- 30 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 May 2012 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 30 May 2012 Actual patients number is 19 as reported by ClinicalTrials.gov.